Fennec Pharmaceuticals (FENC) news
Recent news
FirstEnergy (FE.N): Mizuho cuts target price to $47 from $51
Mizuho has revised its target price for FirstEnergy (FE.N) downward to $47 from $51, reflecting a reassessment of the company’s valuation outlook. The adjustment comes amid ongoing evaluations of utility sector fundamentals, including regulatory developments, operational performance, and broader…
AInvest Wire · 1d agoVallourec shares up 4.4% after winning contract by TotalEnergies for Absheron gas field in Azerbaijan
Vallourec shares rose 4.4% on October 12, 2026, following the announcement that the company had secured a contract with TotalEnergies for the Absheron gas field in Azerbaijan. The contract, part of a broader initiative to develop the Absheron region's energy resources, marks a significant…
AInvest Wire · 1d agoFennec Pharmaceuticals reports second quarter 2026 financial results and provides business update
AInvest Wire · Aug 11, 2026Fennec Pharmaceuticals announces inducement grants under Nasdaq listing Rule 5635(c)(4)
AInvest Wire · Jun 22, 2026Ukraine's Defense Ministry: No official notification of halt in U.S. weapons shipments
AInvest Wire · Jul 2, 2025Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.